Skip to main content
Log in

Long and short QT syndrome

Langes und Kurzes QT-Syndrom

  • REVIEW
  • Published:
Herzschrittmachertherapie & Elektrophysiologie Aims and scope Submit manuscript

Zusammenfassung

In der letzten Dekade ist es durch molekulargenetische Analysen zu erheblichen Fortschritten in unserem Verständnis über primär elektrische Herzerkrankungen gekommen. Das angeborene Long-QT-Syndrom (LQTS) und das kürzlich beschriebene Short-QTSyndrom (SQTS) werden durch eine Dysfunktion kardialer Ionenkanäle hervorgerufen. Die daraus resultierenden Repolarisationsstörungen führen zu einer abnormalen Verlängerung oder Verkürzung der QTc-Zeit im EKG. Diese Ionenkanalerkrankungen zeigen ein hohes Maß an genetischer Heterogenität, welche sich durch eine enorme Variabilität der Genotyp-Phänotyp Relation äußert. Im Folgenden haben wir einen kurzen, klinisch gewichteten Überblick über den aktuellen Wissensstand der molekularen Grundlagen des LQTS und SQTS zusammengestellt.

Summary

In the past decade molecular genetic analysis has greatly expanded our knowledge about inherited arrhythmogenic syndromes. The congenital long QT syndrome (LQTS) and the recently described short QT syndrome (SQTS), with the defining characteristic of abnormal prolongation or shortening of the QTc interval on the surface electrocardiogram, are caused by cardiac ion channel dysfunctions. These “channelopathies” show a high degree of genetic heterogeneity of the molecular pathways in terms of the relationships between genetic defects and phenotypic expression. In this brief review we summarize the current understanding of the molecular basis of long and short QT syndrome with focus on the impact of molecular genetics on the clinical management of these diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Splawski I, Shen J, Timothy KW, Vincent M, Keating MT et al (2000) Spectrum of mutations in long QT syndrome genes. Circulation 102:1178–1185

    PubMed  CAS  Google Scholar 

  2. Moss AJ, Kass RS (2005) Long QT syndrome: from channels to cardiac arrhythmias. J Clin Invest 115:2018–2024

    Article  PubMed  CAS  Google Scholar 

  3. Kääb S, Schulze-Bahr E (2005) Susceptibility genes and modifiers for cardiac arrhythmias. Cardiovasc Res 67:397–413

    Article  PubMed  Google Scholar 

  4. Mohler PJ, Splawski I, Napolitano C, Timothy K, Priori S, Keating MT, Bennett V et al (2004) A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. PNAS 24:9137–9142

    Article  Google Scholar 

  5. Plaster NM, Tawil R, Tristani-Firouzi M et al (2001) Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Anderson Syndrome. Cell 105:511–519

    Article  PubMed  CAS  Google Scholar 

  6. Tristani-Firouzi M, Jensen JL, Donaldson MR et al (2002) Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Anderson syndrome). J Clin Invest 110:381–388

    Article  PubMed  CAS  Google Scholar 

  7. Splawski I, Timothy KW, Sharpe LM et al (2004) Cav1.2 calcium channel dysfunction causes multisystem disorder including arrhythmia and autism. Cell 119:19–31

    Article  PubMed  CAS  Google Scholar 

  8. Priori S, Napolitano C, Vicentini A (2002) Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. J of Interv cardiac Electrophysiol 9:93–101

    Article  Google Scholar 

  9. Moss AJ, Schwartz PJ (2005) 25th anniversary of the international long QT syndrome registry. Circulation 111:1199–1201

    Article  PubMed  Google Scholar 

  10. Priori S, Schwartz PJ, Napolitano C, Capelletti D et al (2003) Risk stratification in the long QT syndrome. N Engl J Med 348:1866–1874

    Article  PubMed  Google Scholar 

  11. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Priori S, Keating MT, Hall WJ et al (1998) Influence of the genotype on the clinical course of the long QT syndrome. N Engl J Med 339:960–965

    Article  PubMed  CAS  Google Scholar 

  12. Vincent GM (2005) Risk assessment in long QT syndrome: the achilles heel of appropriate treatment. Heart Rhythm 2(5):505–506

    Article  PubMed  Google Scholar 

  13. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C et al (2006) ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Eur Heart J 27:2099-2140

    Article  PubMed  Google Scholar 

  14. Moss AJ, Zareba W, Kaufman E, Zang L, Wang Z et al (2002) Increased risk of arrhythmic events in long QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel. Circulation 105:794–799

    Article  PubMed  CAS  Google Scholar 

  15. Rossenbacker T, Mubagwa K, Heidbüchel H, Carmeliet P et al (2005) Novel mutation in the per-arnt-sim domain of KCNH2 causes a malignant form of the long QT syndrome. Circulation 111:961–968

    Article  PubMed  CAS  Google Scholar 

  16. Westenkov P, Splawski I, Timothy K, Keating MT, Sanguinetti MC (2004) Compound mutations. A common cause of severe long QT syndrome. Circulation 109:1834–1841

    Article  Google Scholar 

  17. Kimbrough J, Moss AJ, Zareba W, Robinson JL, Zhang L et al (2001) Clinical implications for affected parents and siblings of probands with long QT syndrome. Circulation 104:557–562

    PubMed  CAS  Google Scholar 

  18. Priori S, Napolitano C, Schwartz PJ (1999) Low penetrance in the long QT syndrome. Circulation 99:529–533

    PubMed  CAS  Google Scholar 

  19. Moss AJ, Zareba W, Hall WJ, Andrews ML et al (2000) Effectiveness and limitations of betablocker therapy in congenital long-QT syndrome. Circulation 101:616–623

    PubMed  CAS  Google Scholar 

  20. Schwartz PJ, Priori S, Cerrone M, Zareba W, Epstein AE, Li C, Hu D et al (2004) Left cardiac sympathetic denervation in the management if highrisk patients affected by the long QT syndrome. Circulation 109:1826–1833

    Article  PubMed  Google Scholar 

  21. Dorostkar PC, Eldar M, Belhassen B, Scheinman MM (1999) Long-term follow-up of patients with long QT syndrome with betablocker and continuous pacing. Circulation 100:2431–2436

    PubMed  CAS  Google Scholar 

  22. Mönnig G, Köbe J, Löher A, Eckardt L, Breithardt G, Schulze-Bahr E, Böcker D et al (2005) Implantable cardioverter-defibrillator therapy in patients with congenital long QT syndrome: a long term follow up. Heart Rhythm 2:497–504

    Article  PubMed  Google Scholar 

  23. Rajamani S, Anderson CL, Anson BD, January CT (2002) Pharmacological rescue of human K channel long QT2 mutations. Circulation 105:2830–2835

    Article  PubMed  CAS  Google Scholar 

  24. Gepstein L, Feld Y, Yankelson L (2004) Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. Am J Physiol 286:H815–822

    CAS  Google Scholar 

  25. Phillips KA, Ackerman MJ, Sakowski J, Berul CI (2005) Cost-effectiveness analysis of genetic testing for familial long QT syndrome in symptomatic index cases. Heart Rhythm 2:1294–1300

    Article  PubMed  Google Scholar 

  26. Gussak I, Brugada P, Brugada J et al (2000) Idiopathic short QT interval: a new clinical syndrome? Cardiology 94:99–102

    Article  PubMed  CAS  Google Scholar 

  27. Brugada R, Hong K, Dumaine R, Brugada P, Antzelevitch C et al (2004) Sudden death associated with short QT syndrome linked to mutations in HERG. Circulation 109:30–35

    Article  PubMed  CAS  Google Scholar 

  28. Bellocq C, van Ginneken ACG, Bezzina CR, Wilde AA et al (2004) Mutation in the KCNQ1 gene leading to the short QT-interval syndrome. Circulation 109:2394–2397

    Article  PubMed  Google Scholar 

  29. Priori S, Pandit SV, Rivolta I, Berenfeld O, Jalife J et al (2005) A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene. Circ Res 96:800–807

    Article  PubMed  CAS  Google Scholar 

  30. Schulze-Bahr E (2005) Short QT syndrome or Andersen syndrome. Yin and Yang of Kir2.1 channel dysfunction. Circ Res 96:703–704

    Article  PubMed  CAS  Google Scholar 

  31. Cerrone M, Noujaim S, Jalife J (2006) The short QT syndrome as a paradigm to understand the role of potassium channels in ventricular fibrillation. J Intern Med 259:24–38

    Article  PubMed  CAS  Google Scholar 

  32. Schimpf R, Bauersfeld U, Gaita F, Wolpert C (2005) Short QT syndrome: successful prevention of sudden death in an adolescent by implantable cardioverter-defibrillator treatment for primary prophylaxis. Heart Rhythm 2:416–417

    Article  PubMed  Google Scholar 

  33. Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Haissaguerre M, Calo L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C (2004) Short QT syndrome: pharmacological treatment. J Am Coll Cardiol 43:1494–1499

    Article  PubMed  CAS  Google Scholar 

  34. Gaita F, Giustetto C, Bianchi F, Wolpert C, Schimpf R, Riccardi R, Grossi S, Richardi E, Borggrefe M (2003) Short QT syndrome: a familial cause of sudden death. Circulation 108:965–970

    Article  PubMed  Google Scholar 

  35. Schimpf R, Wolpert C, Gaita F, Giustetto C, Borggrefe M (2005) Short QT syndrome. Cardiovasc Res 67(3):357–366

    Article  PubMed  CAS  Google Scholar 

  36. Brugada R, Hong K, Cordeiro JM, Dumaine R (2005) Short QT syndrome. CMAJ 173(11):1349–1354

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Stellbrink.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Borchert, B., Lawrenz, T. & Stellbrink, C. Long and short QT syndrome. Herzschr. Elektrophys. 17, 205–210 (2006). https://doi.org/10.1007/s00399-006-0534-9

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00399-006-0534-9

Schlüsselwörter

Key words

Navigation